Abstract
Background
Reduced glomerular filtration rate (GFR) is strongly associated with reduced survival in patients with chronic heart failure (CHF). Our aim was to determine different pathophysiologic markers that are associated with reduced renal function in CHF.
Methods and results
We studied 86 patients with CHF (58 ± 12 years, 78% male). GFR and renal blood flow (RBF) were determined by 125I-Iothalamate and 131I-Hippuran clearances. Filtration fraction (FF) was calculated. We determined haemoglobin levels, endothelial function, inflammatory status, plasma renin activity (PRA) and N-terminal pro brain natriuretic peptide (NT-proBNP). Urinay albumin excretion (UAE) was measured in 24 h urine. Mean GFR was 74 ± 28 ml/min/1.73 m2. GFR was strongly related to RBF (r = 0.915, P < 0.001), FF (r = 0.546, P < 0.001), but only weakly to endothelial function and PRA. In multivariate analysis, RBF (r = 0.938, P < 0.001), FF (r = 0.786, P < 0.001) and haemoglobin levels (r = −0.520, P < 0.001) were independently associated with GFR. UAE was mainly dependent on RBF (r = −0.401, P < 0.001) and increased exponentially with decreasing RBF. RBF was mainly associated with NT-proBNP (r = −0.561, P < 0.001) and PRA (r = −0.422, P < 0.001).
Conclusion
Reduced GFR is mainly dependent of decreased RBF in patients with CHF. Endothelial function and neurohormonal activation showed only mild associations with GFR. NT-proBNP showed a strong relationship with RBF, and may be used as a marker of reduced renal perfusion.
Similar content being viewed by others
References
Bohm M, Werner N, Kindermann M (2006) Drug treatment of chronic heart failure. Clin Res Cardiol 95(Suppl 4):36–54
Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17
Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A (1998) Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79:399–407
Brezis M, Rosen S (1995) Hypoxia of the renal medulla–its implications for disease. N Engl J Med 332:647–655
Brown MJ (2007) Renin: friend or foe? Heart 93:1026–1033
Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GY (2006) Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Am J Cardiol 97:671–675
Cody RJ, Ljungman S, Covit AB, Kubo SH, Sealey JE, Pondolfino K, Clark M, James G, Laragh JH (1988) Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 34:361–367
Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2008) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol accepted for publication
Damman K, Navis G, Smilde TD, Voors AA, van der BW, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878
Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S (2007) The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 13:609–617
Donker AJM, Vanderhem GK, Sluiter WJ, Beekhuis H (1977) Radioisotope method for simultaneous determination of glomerular-filtration rate and effective renal plasma-flow. Neth J Med 20:97–103
Evans RG, Eppel GA, Anderson WP, Denton KM (2004) Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 22:1439–1451
Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC (2007) The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50:1551–1560
Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de ZD, Charlesworth A, Hampton JR, van Veldhuisen DJ (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203–210
Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de ZD, Pocock S, van Veldhuisen DJ (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678
Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, de Zeeuw D (2003) Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 24:412–420
Ingelsson E, Sundstrom J, Lind L, Riserus U, Larsson A, Basu S, Arnlov J (2007) Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J 28:1739–1745
Jensen KT, Carstens J, Pedersen EB (1998) Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 274:F63–F72
Kilcoyne MM, Schmidt DH, Cannon PJ (1973) Intrarenal blood flow in congestive heart failure. Circulation 47:786–797
La Villa G, Fronzaroli C, Lazzeri C, Porciani C, Bandinelli R, Vena S, Messeri G, Franchi F (1994) Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. J Clin Endocrinol Metab 78:1166–1171
Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart-failure—relationship of cardiac index to kidney-function. Drugs 39:10–21
Marcus LS, Hart D, Packer M, Yushak M, Medina N, Danziger RS, Heitjan DF, Katz SD (1996) Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: a double-blind, placebo-controlled, randomized crossover trial. Circulation 94:3184–3189
Nushiro N, Ito S, Carretero OA (1990) Renin release from microdissected superficial, midcortical, and juxtamedullary afferent arterioles in rabbits. Kidney Int 38:426–431
Pollock CA, Poronnik P (2007) Albumin transport and processing by the proximal tubule: physiology and pathophysiology. Curr Opin Nephrol Hypertens 16:359–364
Prevot A, Huet F, Semama DS, Gouyon JB, Guignard JP (2002) Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit. Life Sci 71:779–787
Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF (2001) Renal function: the cinderella of cardiovascular risk profile. J Am Coll Cardiol 38:1782–1787
Smilde TDJ, Hillege HL, Voors AA, Dunselman PHJ, van Veldhuisen DJ (2004) Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction. Am J Cardiol 94:240–243
Stam F, van GC, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD (2006) Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol 17:537–545
Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206
van de Wal RM, Asselbergs FW, Plokker HW, Smilde TD, Lok D, van Veldhuisen DJ, van Gilst WH, Voors AA (2005) High prevalence of microalbuminuria in chronic heart failure patients. J Card Fail 11:602–606
van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA (2006) Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol 106:367–372
van der Harst P, Smilde TD, Buikema H, Voors AA, Navis G, van Veldhuisen DJ, van Gilst WH (2006) Vascular function and mild renal impairment in stable coronary artery disease. Arterioscler Thromb Vasc Biol 26:379–384
van der Horst I, Voors AA, van Veldhuisen DJ (2007) Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists? Clin Res Cardiol 96:193–195
van der Zander K, Houben AJ, Hofstra L, Kroon AA, de Leeuw PW (2003) Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study. Am J Physiol Heart Circ Physiol 285:H1206–H1212
Wannamethee SG, Shaper AG, Lowe GD, Lennon L, Rumley A, Whincup PH (2006) Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. Eur Heart J 27:2975–2981
Acknowledgments
K. Damman and P. van der Harst are supported by the Netherlands Heart Foundation (grants 2006B157 and 2006B003, respectively). A.A. Voors and D.J. van Veldhuisen are Clinical Established Investigators of the Netherlands Heart Foundation (grants 2006T37 and D97-017, respectively). P. van der Harst is a research fellow of the Interuniversitair Cardiologisch Instituut Nederland (ICIN).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smilde, T.D.J., Damman, K., van der Harst, P. et al. Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol 98, 121–129 (2009). https://doi.org/10.1007/s00392-008-0732-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-008-0732-z